In contrast, the coculture of the tumor cells combined with the selective activation of Vγ9Vδ2 T cells within the PBMC by zoledronate increased galectin-3 release within 72 hours (Figures 2B, D, F). The gene discussed is LGALS3; the disease is neoplasm.